|Articles|July 30, 2018

Legionella Bacteria Detected in Two New York City Boroughs

Legionella bacteria were detected in the water supply of a Bronx hospital as cases of Legionnaires’ disease rise in Lower Washington Heights cluster.

Health officials in New York City are working to minimize the threat of Legionella bacteria across the city as a cluster of Legionnaires’ disease cases has been identified Lower Washington Heights. Legionella bacteria were also detected in the water supply of a hospital in the Bronx.

Legionnaires’ disease is not unfamiliar to the city of New York. Outbreaks have been reported there since 1985; the last major outbreak, which included 138 cases and 15 deaths, occurred in the South Bronx in the summer of 2015. That outbreak was regarded as one of the largest and deadliest outbreaks of Legionnaires’ disease in US history. All the cases were linked to a cooling tower in the South Bronx.

As part of the investigation into the current outbreak, New York City Department of Health officials are sampling and testing water from the cooling tower systems in the Lower Washington Heights in the borough of Manhattan, to determine if they are the source of the Legionella contaminated water causing the current cluster of cases.

“The Health Department has identified a cluster of Legionnaires’ disease in the Lower Washington Heights area,” said Health Commissioner Mary T. Bassett, MD, in a statement, “[T]his disease is very treatable with antibiotics. I encourage anyone with symptoms of Legionnaires’ disease to seek care early.”

In the initial announcement of the investigation, released on July 11, the Department of Health reported 8 diagnosed cases of Legionnaires’ Disease in Lower Washington Heights. Since then, the case counts have tripled and a representative for the New York City Department of Health told Contagion® that as of July 26, the current count is 27 cases of Legionnaires’ disease and 1 death.

Across the city in the Bronx, health officials have confirmed that Legionella bacteria were found in the water supply of the Jacobi Medical Center. In a statement to Contagion® NYC Health + Hospitals officials explained the steps they are taking to ensure the health of their patients.

“As part of our aggressive water monitoring program, our routine, required testing of our potable water supply found very low levels of Legionella bacteria at NYC Health + Hospitals/Jacobi,” they shared. “Per guidance from the New York State Department of Health, which regulates hospitals, we have taken steps to prevent any impact on our patients, staff, or visitors. Safety is always our highest priority.”

According to the health officials, the levels of Legionella bacteria were not high. Patients and staff have been made aware of the finding; however, the risk of infection is low. Still, the hospital has taken precautionary measures to decrease the risk of infection by providing bottled water, packaged bath wipes, and installing new water filters on the shower heads.

According to the US Centers for Disease Control and Prevention’s immediate control measures for health care facilities with water containing Legionella bacteria, water restrictions and the use of filters should continue to be implemented until the source of the bacteria has been identified.

Symptoms of Legionnaires’ disease are similar to other types of pneumonia which can include fever, chills, muscle aches, and cough. Individuals only get sick by breathing in water vapor and the disease cannot be transmitted from person-to-person. Populations at a higher risk for infection include individuals over 50 years of age, individuals who smoke cigarettes and individuals with chronic lung disease or a weakened immune system.

At this time, there is no evidence to suggest that the cluster of Legionnaires’ disease in Lower Washington Heights is connected with the Legionella bacteria detected in the drinking water at Jacobi Medical Center in the Bronx. The NYC Department of Health advises any person living in the Lower Washington Heights area experiencing symptoms should seek medical attention.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.